Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Ke

Showing results (491-500 of 506) with videos related to

Pageof 51
Sort By:
Journal of Medicinal Chemistry|January 10, 2018
Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and BeyondChien-Huang Wu, Jen-Shin Song, Hsuan-Hao Kuan, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Bromomethylthioindole Inspired Carbazole Hybrids as Promising Class of Anti-MRSA AgentsChia-Yi Cheng, Chun-Ping Chang, Tsai-Ling Yang Lauderdale, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2025
Stroma-targeted gene delivery for efficient immunogene therapy against pancreatic cancerHsi-Chien Huang, Yi-Ju Chen, Mei-Wei Lin, et al.
Cancer Letters|May 26, 2025
CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancersXiao-Liang Jie, Jia-Cong Wei, Di Wang, et al.
Journal of Medicinal Chemistry|May 19, 2021
Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC OncoproteinsYa-Hui Chi, Teng-Kuang Yeh, Yi-Yu Ke, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2020
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2Hui-Chen Hung, Yi-Yu Ke, Sheng Yu Huang, et al.
Journal of Medicinal Chemistry|September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung CancerShu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry|January 14, 2015
Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitorsChien-Huang Wu, Chuan-Jen Wang, Chun-Ping Chang, et al.
World Journal of Gastroenterology|June 20, 2025
Evaluating log odds of positive lymph nodes as a prognostic tool in differentiated gastric cancer: A retrospective studyMing-Cong Deng, Ken Chen, Qi-Mei Bao, et al.
Pageof 51

Showing results (491-500 of 506) with videos related to

Sort By:
Pageof 51
Journal of Medicinal Chemistry|January 10, 2018
Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and BeyondChien-Huang Wu, Jen-Shin Song, Hsuan-Hao Kuan, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Bromomethylthioindole Inspired Carbazole Hybrids as Promising Class of Anti-MRSA AgentsChia-Yi Cheng, Chun-Ping Chang, Tsai-Ling Yang Lauderdale, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2025
Stroma-targeted gene delivery for efficient immunogene therapy against pancreatic cancerHsi-Chien Huang, Yi-Ju Chen, Mei-Wei Lin, et al.
Cancer Letters|May 26, 2025
CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancersXiao-Liang Jie, Jia-Cong Wei, Di Wang, et al.
Journal of Medicinal Chemistry|May 19, 2021
Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC OncoproteinsYa-Hui Chi, Teng-Kuang Yeh, Yi-Yu Ke, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2020
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2Hui-Chen Hung, Yi-Yu Ke, Sheng Yu Huang, et al.
Journal of Medicinal Chemistry|September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung CancerShu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry|January 14, 2015
Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitorsChien-Huang Wu, Chuan-Jen Wang, Chun-Ping Chang, et al.
World Journal of Gastroenterology|June 20, 2025
Evaluating log odds of positive lymph nodes as a prognostic tool in differentiated gastric cancer: A retrospective studyMing-Cong Deng, Ken Chen, Qi-Mei Bao, et al.
Pageof 51